Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2612 of 5804
-
Could a Fatty-Acid drug help kids with rare energy disorder?
Disease control Recruiting nowThis is a medical research study to test a medication in patients with a disease called Pyruvate Dehydrogenase Complex (PDC) Deficiency. The medication is triheptanoin, which is currently FDA approved for the treatment of Long-Chain Fatty Acid Oxidation Disorders. Previous resear…
Phase: PHASE1 • Sponsor: Jirair Krikor Bedoyan • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a freezing device loosen stiff muscles? new trial begins
Symptom relief OngoingThis multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper extremity spasticity. A total of approximately 132 subjects will be enrolled; 88 subjects will receive treatment with the…
Phase: NA • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New behavioral program aims to ease distress over routine changes in autistic kids
Symptom relief Recruiting nowThe purpose of this open label trial is to examine the preliminary feasibility, acceptability, and effectiveness of a 12-week behavioral intervention program (1 hour/week) to treat insistence on sameness (e.g., difficulty tolerating changes in routine) in youth with autism spectr…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Breathing your way to better sleep: new study targets Emotion-Linked insomnia
Symptom relief OngoingIn recent years, the incidence of sleep disorders, especially insomnia, has been rising. Insomnia can directly lead to damage to patients' daytime functions, such as daytime sleepiness, inattention, etc., affecting people's normal work and life. Insomnia is related to dysfunction…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Diabetes drug could help rare kidney disease patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if an oral drug called dapagliflozin is safe and can reduce high protein levels in the urine of patients with renal amyloid light-chain (AL) amyloidosis using a decentralized study design. Participants will be: * screened for the tria…
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Phone program aims to ease chronic pain for rural veterans
Symptom relief OngoingThis is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care …
Phase: PHASE3 • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Magnetocardiography device could spot heart attacks faster
Knowledge-focused Recruiting nowPRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Sponsor: SB Technology, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Experimental cell therapy targets Hard-to-Treat ovarian cancers
Disease control OngoingThis is a single center Phase I clinical trial of FT536 administered intraperitoneally (IP) 3 times a week for one week for the treatment of recurrent gynecologic cancers. A short course of outpatient lymphodepleting chemotherapy is given prior to the first dose of FT536 to promo…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Tablet tool aims to boost pregnancy care in south asia
Knowledge-focused OngoingOur research aims to address a critical gap in the provision of quality antenatal care (ANC) in India and Nepal, by developing and evaluating an intervention comprising of a tablet-based electronic decision support system (EDSS). This intervention -"mIRA" - is an mHealth integrat…
Phase: NA • Sponsor: Public Health Foundation of India • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Sugar-water shots and exercise may soothe knee arthritis pain
Symptom relief CompletedThe aim of this clinical trial is to assess whether prolotherapy combined with personal physical activity is effective in managing pain (measured using the VAS and WOMAC scales) and improving the quality of life in participants with Grade 2 Knee Osteoarthritis (OA). This trial w…
Phase: NA • Sponsor: Gadjah Mada University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Retraining the brain to turn down neck pain — a new approach put to the test
Symptom relief CompletedNeck pain is one of the most common musculoskeletal pain disorders secondary to low back pain. Pharmacological and non-medical treatments such as physiotherapy are applied in its treatment. Patients with chronic nonspecific neck pain (CNSP) can be treated with various interventio…
Phase: NA • Sponsor: Acibadem University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Magnetic pulses may protect knees from osteoarthritis damage
Disease control CompletedKnee osteoarthritis is a condition that affects young or middle-aged patients with high functional demands. Knee replacement surgery in patients under 65 years of age is associated with a high risk of failure and the need for revision. For this reason, it becomes crucial to ident…
Phase: NA • Sponsor: Stefano Zaffagnini • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New program aims to ease diabetes distress in teens
Symptom relief Recruiting nowThe investigators will assess both effectiveness (primary) and implementation (secondary) outcomes for a distress-reducing intervention, Supporting Teen Problem Solving (STePS). STePS has already undergone an efficacy trial. The current study allows for evaluating the outcomes of…
Phase: NA • Sponsor: Jill Weissberg-Benchell, Ph.D. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to calm agitation in Alzheimer's patients
Symptom relief CompletedThis study consists of 2 parts, Part A and Part B. Part A is a single center, randomized, double-blind, placebo-controlled cohort designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of NMRA-323511 among healthy elderly. Part B is a multicenter, randomized, d…
Phase: PHASE1 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
3D-Printed device could make breathing tubes safer for obese patients
Symptom relief CompletedThis study is looking for a better way to secure breathing tubes for obese patients who need them. For patients with obesity, a short neck and extra tissue can make it difficult to keep a breathing tube in the correct position. When a tube moves, it can cause serious problems. R…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could a simple injection stop type 1 diabetes before it starts?
Prevention OngoingA 2-arm randomized Phase II Open Label Study to evaluate the safety and feasibility of intralymphatic administration of Diamyd® (Diamyd) also known as retogatein in individuals at risk of Type 1 diabetes carrying the HLA DR3-DQ2 haplotype.
Phase: PHASE2 • Sponsor: Diamyd Medical AB • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
New approach: antibiotics delivered straight to the infection site during ERCP
Disease control Recruiting nowDoes intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?
Phase: PHASE2 • Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Booster shot could boost supply of lifesaving infant botulism treatment
Disease control CompletedThis Phase 2, open-label, uncontrolled study designed to evaluate safety, tolerability, and immunogenicity of a single dose of rBV A/B in healthy participants previously immunized with pentavalent botulinum toxoid (or pentavalent botulinum toxoid and rBV A/B) for occupational pro…
Phase: PHASE2 • Sponsor: California Department of Public Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control CompletedThis is a multicenter, open label phase II clinical study to evaluate the efficacy and safety of AK120 in the treatment of subjects with moderate to severe atopic dermatitis.
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for tough lymphoma: experimental drug enters human testing
Disease control Recruiting nowThis is an open-label, multiple ascending dose (MAD), phase 1 study in adult patients with relapsed or refractory (R/R) B cell non-Hodgkin lymphoma (B-NHL). The purpose of the study is to identify possible optimal biological dosage(s) by assessing safety, tolerability, pharmacoki…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC